期刊文献+

大肠癌端粒酶及其相关因子表达的研究

下载PDF
导出
摘要 目的:探讨端粒酶相关因子表达在大肠癌发生、发展以及浸润转移中的意义。方法:采用Southern-blot及端粒重复序列扩增法(Telomeric Repeat Amplification Protocol,PCR)测定端粒长度和端粒酶活性,免疫组化方法测定端粒酶催化亚基(Hu-man Telomerase Reverse Transcriptase,hTERT)以及p53、C-myc的表达。结果:端粒酶活性和hTERT在大肠癌组织中的表达率明显提高,相反,大肠癌平均端粒长度则明显缩短;低分化大肠癌组织中的端粒酶和hTERT表达明显高于中分化及高分化大肠癌;伴淋巴结转移大肠癌端粒酶和hTERT阳性表达明显高于无淋巴结转移者;p53和C-myc在大肠癌中的表达明显高于癌旁肠组织、正常大肠黏膜组织及腺瘤性息肉,C-myc蛋白在端粒酶活性阳性的大肠组织中的表达率为87.76%(43/49)明显高于端粒酶阴性组31.25%(5/16)(P<0.01),而p53在端粒酶活性阳性及阴性组中的表达率分别为79.79%(39/49)和62.50%(10/16),两者差异无统计学意义(P>0.05)。结论:端粒长度改变及端粒酶高表达可能与大肠癌的发生有密切关系,端粒酶表达水平的高低与肿瘤细胞侵袭、肿瘤进展和转移相关;C-myc蛋白可能参与端粒酶激活。
出处 《广西医科大学学报》 CAS 北大核心 2006年第4期553-555,共3页 Journal of Guangxi Medical University
基金 广西卫生厅医药卫生科研课题(项目编号:9954)
  • 相关文献

参考文献9

  • 1赵东兵,张伟,金顺钱,刘毅,常绍静,邵永孚.大肠癌组织中端粒酶活性的研究[J].中华肿瘤杂志,1998,20(3):199-201. 被引量:25
  • 2Fromowitz FB,Viola MV,Chao S,et al.ras p21expression in progression of breast cancer.Hum Pathol,1987,18(12):1268-1275.
  • 3Sarkar G,Bolander ME.Telomeres,telomeresand cancer.Science,1995,26(4):413-419.
  • 4Latil A,Vidaud D,Valeri A,et al.hTERT expression colorectes with MYC over-expression in human prostate cancer.Iht J Cancer Res,2000,89(2):172-176.
  • 5Wang J,Xei LY,Allan S,et al.MYC activates telomerase.Genes Dev,1998,12(12):1769-1774.
  • 6刘剑仑,葛莲英,张贵年.p53、c-myc、PCNA在大肠癌过度表达的临床意义[J].大肠肛门病外科杂志,2004,10(1):21-23. 被引量:11
  • 7Henderson YC,Breau RL,Liu TJ,et al.telomerase activity in head and neck tumors after introduction of type p53,p21,p16 and E2F-1 genes by means of recombinant adenoviral.Head Neck,2000,22(4):347-354.
  • 8Kanaya T,Kyo S,Hanaya K,et al.Adenoviral expression of p53 reprease telomerase activity through downegution of human telomerase reverse transcriptase transcription.Clin Cancer Res,2000,6(4):1239-1247.
  • 9Li H,Cao Y,Berndt MC,et al.Molecular interactions between telomerase and the tumor suppressor protein p53in vitro.Oncogen,1999,18(48):6785-6794.

二级参考文献9

  • 1Lane DP. Cancer. p53, guardian of the genome. Nature,1992, 358: 15-16.
  • 2Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA, 1990, 87:7555-7559.
  • 3Kelly K, Cochra BH, Stiles CD, et al. Cell-specific regulation of the c-myc gene by lymphocyte mitogen and platelet-derived growth factor. Cell, 1983, 35: 603-610.
  • 4Taub RM, Mouldin G, Cbatley J, et al. Activation and somatic mutation in the translocated c-myc gene in Burkitt's lymphoma. Cell, 1984, 36: 339-348.
  • 5Penney NS, Boaert M, Serfling V, et al. PCNA expression in cutaneaus keratinous neoplasms and verruca vulgous. Am J Pathol, 1992, 141: 139-142.
  • 6Boron WE, Mikulka WK, Healy CG, et al. Expression of proliferation associated antigen in the cell cycle of synchronized mammalian cells. Cytometry, 1992,13 : 117-126.
  • 7Bravo R, Frank R, Blundell PA, Macdonald-Bravo H.Cyclin/PCNA is the auxilliary protein of DNA polymerase delta. Nature, 1987, 326: 515-517.
  • 8Hall PA, Levision DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections. J Pathol, 1990, 162:285 294.
  • 9蒋建飞,国外医学.肿瘤学分册,1997年,24卷,29页

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部